Study reveals novel approach to promote efficient uptake of ASOs into cancer cells

Antisense oligonucleotides (ASOs) are next-generation drugs that can treat disease by blocking the transfer of harmful messages from our genes.

Revealing the hidden role of blood leaks in Alzheimer’s and MS

The question of what causes complex neurological diseases such as Alzheimer’s or multiple sclerosis continues to confound scientists and doctors, with the unknowns standing in

October 18, 2024

NHS still faces waiting list challenges

Commenting on the publication today of the NHS monthly performance statistics, Tim Gardner, Assistant Director of Policy at the Health Foundation, said.

May 11, 2024

Eating Disorders After GLP-1s? Tirzepatide for Heart Failure; Soda Taxes and BMI

Weight-loss drugs like tirzepatide (Zepbound) and semaglutide (Wegovy) may trigger eating disorders in certain patients, doctors warned. (NBC News) In a placebo-controlled phase III trial,

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.